SUNESIS PHARMACEUTICALS
Sunesis is an emerging biopharmaceutical company creating new medicines to improve the lives of people with cancer. They are building a pipeline of drugs that selectively block critical mechanisms required for tumor growth and survival. The fight against cancer is an enormous mission that requires an integrated approach fueled by a commitment to innovation.
SUNESIS PHARMACEUTICALS
Industry:
Biotechnology Health Care Pharmaceutical
Founded:
1998-01-01
Address:
South San Francisco, California, United States
Country:
United States
Website Url:
http://www.sunesis.com
Total Employee:
51+
Status:
Active
Contact:
650) 266-3500
Email Addresses:
[email protected]
Total Funding:
171.7 M USD
Technology used in webpage:
SPF Microsoft Exchange Online Office 365 Mail ReCAPTCHA Cloudflare Hosting Cloudflare DNS ReCAPTCHA V2 Internap Thomson Reuters Corporate Solutions
Similar Organizations
Salix Pharmaceuticals
Salix Pharmaceuticals is a specialty pharmaceutical companyย focused on theย prevention and treatment of gastrointestinal disorders.
Current Advisors List
Current Employees Featured
Founder
Stock Details
Investors List
Bridge Bank
Bridge Bank investment in Post-IPO Debt - Sunesis Pharmaceuticals
Caxton Advantage Life Sciences Fund
Caxton Advantage Life Sciences Fund investment in Post-IPO Equity - Sunesis Pharmaceuticals
OpusPoint Partners
OpusPoint Partners investment in Post-IPO Equity - Sunesis Pharmaceuticals
Bay City Capital
Bay City Capital investment in Post-IPO Equity - Sunesis Pharmaceuticals
Alta Partners
Alta Partners investment in Post-IPO Equity - Sunesis Pharmaceuticals
New Enterprise Associates
New Enterprise Associates investment in Post-IPO Equity - Sunesis Pharmaceuticals
Merlin Nexus
Merlin Nexus investment in Post-IPO Equity - Sunesis Pharmaceuticals
Vision Capital Advisors
Vision Capital Advisors investment in Post-IPO Equity - Sunesis Pharmaceuticals
Venrock
Venrock investment in Post-IPO Equity - Sunesis Pharmaceuticals
Nextech Invest
Nextech Invest investment in Post-IPO Equity - Sunesis Pharmaceuticals
Official Site Inspections
http://www.sunesis.com
- Host name: a904c694c05102f30.awsglobalaccelerator.com
- IP address: 76.223.54.146
- Location: Seattle United States
- Latitude: 47.54
- Longitude: -122.3032
- Metro Code: 819
- Timezone: America/Los_Angeles
- Postal: 98108